NCT01547520View on ClinicalTrials.gov

Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Esophagogastroduodenoscopy
Interventions
DRUG

Meperidine

intramuscular, 25 mg, 5 to 10 minutes before EGD

DRUG

normal saline

25 ml of normal saline, intramuscular, 5 to 10 minutes before EGD

Trial Locations (1)

622

Dalin Tzu Chi General Hospital, Chiayi City

All Listed Sponsors
lead

Dalin Tzu Chi General Hospital

OTHER

NCT01547520 - Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy | Biotech Hunter | Biotech Hunter